A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 146 shares of EW stock, worth $10,275. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146
Previous 202 27.72%
Holding current value
$10,275
Previous $18.7 Million 48.36%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$59.7 - $93.78 $3,343 - $5,251
-56 Reduced 27.72%
146 $9.64 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $3,877 - $4,338
46 Added 29.49%
202 $18.7 Million
Q1 2024

May 10, 2024

BUY
$72.54 - $95.56 $10,590 - $13,951
146 Added 1460.0%
156 $14.9 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $617 - $777
10 New
10 $763,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Foster Dykema Cabot & Partners, LLC Portfolio

Follow Foster Dykema Cabot & Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Dykema Cabot & Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foster Dykema Cabot & Partners, LLC with notifications on news.